Literature DB >> 16473240

Complications arising from iris-fixated posterior chamber intraocular lenses.

Terry L Kaiura1, John A Seedor, Richard S Koplin, Michelle K Rhee, David C Ritterband.   

Abstract

Iris fixation of posterior chamber intraocular lenses (IOLs) is a technique that has been recommended for patients in whom a posterior chamber IOL is indicated but there is insufficient capsular support. We present 4 cases of iris-fixated posterior chamber IOLs with complications related to the procedure. Three patients developed postoperative slippage of the IOL, and 1 patient presented with iris erosion of the haptic leading to recurrent hemorrhage. Three cases were repaired by resuturing the same IOL using iris fixation, and in the last case IOL exchange with transscleral fixation of a posterior chamber IOL was performed. Final follow-up revealed stable IOLs in all cases.

Entities:  

Mesh:

Year:  2005        PMID: 16473240     DOI: 10.1016/j.jcrs.2005.06.048

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  4 in total

1.  Ocular biocompatibility of nitinol intraocular clips.

Authors:  Jeffrey L Olson; Raul Velez-Montoya; Michael Erlanger
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

Review 2.  [Iris suture fixation of posterior chamber lenses. New perspectives for an old technique].

Authors:  K Gerstmeyer; W Sekundo
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

3.  Retropupillary Fixation of Iris-Claw Intraocular Lens for Aphakic Eyes in Children.

Authors:  Martina Brandner; Sarah Thaler-Saliba; Sophie Plainer; Bertram Vidic; Yosuf El-Shabrawi; Navid Ardjomand
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

4.  Retropupillary iris-claw intraocular lens for the surgical correction of aphakia in cases with microspherophakia.

Authors:  Sameh Mosaad Fouda; Mahmoud A Al Aswad; Basem M Ibrahim; Ashraf Bori; Hala K Mattout
Journal:  Indian J Ophthalmol       Date:  2016-12       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.